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PseudovirionThe deduced amino acid (aa) sequence of L2 of the newly sequenced HPV51 strain, isolated by Matsukura and
Sugase (Ma-strain), was markedly different from that of the prototype HPV51 isolated by Nuovo et al. (Nu-
strain) (GenBank M62877) in two regions: aa 95–99 (region I) and aa 179–186 (region II). The two regions of
Ma-strain were homologous to those of the other mucosal HPVs. The aa sequences of the N-terminal and C-
terminal regions of Ma-L2 and Nu-L2 were identical and contained the nuclear localizing signal (NLS). When
expressed in HEK293 cells, Ma-strain L2 (Ma-L2) was located in the nucleus but Nu-strain L2 (Nu-L2), in the
cytoplasm. The chimeric L2s having bothNu-L2 regions I and IIwere located in the cytoplasm, and those having
one of themwere located both in the nucleus and cytoplasm, suggesting that Nu-L2 regions I and II inhibit the
NLS function. For a better understanding of a role of L2 in infection, pseudovirion (PV) preparations were
produced with a reporter, Ma-strain L1, and various L2s (Ma-L2, Nu-L2, or the chimeric L2s). These PV
preparations contained structurally similar particles composed of L1 and L2 and the packaged reporter plasmid
at a similar level. The reporter expression was not induced in HEK293 cells after inoculation with PVs
containing the L2s that are incapable of localizing in the nucleus when expressed alone. Among PVs containing
L2s capable of localizing in the nucleus, the reporter expression was induced only by PVs containing Ma-L2
region I. Thus, the results indicate that the expression of the reporter in the HPV51 PV requires the nuclear
localizing ability of L2 and another unknown function associated with region I.
© 2009 Elsevier Inc. All rights reserved.Introduction
Human papillomavirus (HPV) is a small nonenveloped virus with
circular double-stranded DNA genome (8000 base-pairs) packaged in
an icosahedral capsid composed of two capsid proteins L1 (major) and
L2 (minor) (Howley and Lowy, 2001). Various HPVs, which have been
identiﬁed in proliferative lesions including cervical cancer, are
classiﬁed into more than 100 genotypes based on the homology of
nucleotide sequence of L1 gene (Howley and Lowy, 2001). HPV infects
the epithelium and propagates in the differentiating keratinocytes or
establishes a latent state in the epithelial basal cells (Howley and
Lowy, 2001). There are no cell cultures supporting efﬁcient HPV
propagation.
Infectious HPV pseudovirions have been developed (Unckell et al.,
1997; Stauffer et al., 1998; Buck et al., 2004) and are used as a
surrogate virus to study biological functions and immunogenicity of
the capsid proteins (Sapp and Selinka, 2005; Buck et al., 2005). The
mRNAs transcribed from the codon-modiﬁed L1 and L2 genes escapell rights reserved.from the mechanism inducing the rapid degradation of the authentic
L1- and L2-mRNAs in the undifferentiated cells (Sokolowski et al.,
1998; Collier et al., 2002). L1 and L2 expressed in cultured cells from
the codon-modiﬁed genes self-assemble to form L1/L2 virus-like
particles (L1/L2-VLPs) in the nucleus. When L1 and L2 are expressed
in the SV40 T-antigen positive cells transfected with a reporter
plasmid carrying SV40-ori, the replicating reporter plasmid is
packaged into the L1/L2-VLP to produce a pseudovirion (PV) (Buck
et al., 2004). Because the efﬁciency of the packaging is not high, a
semi-puriﬁed PV preparation contains complete PVs and empty L1/
L2-VLPs. The reporter is expressed at a readily detectable level in the
cells inoculated with the PV preparation.
According to the registered nucleotide sequence of HPV51 DNA
(GenBank M62877), isolated from cervical condyloma by Nuovo et al.
(1988) and sequenced by Lungu et al. (1991), the deduced amino acid
(aa) of the HPV51 L2 is markedly different from those of the other
mucosal HPVs in two regions, aa 95–99 (region I) and aa 179–186
(region II) (Fig. 1A). This led us to newly sequence the L2 gene of
another HPV51 isolated from a Japanese woman with CIN (Matsukura
and Sugase, 1995). In this study, we found that the two regions of the
new isolate were different from those of the prototype but
homologous to those of the other mucosal HPVs. We prepared and
Fig. 1. Amino acid sequence of L2. (A) Amino acid sequences of L2 aa 95–99 (region I) and aa 179–186 (region II) of prevalent mucosal HPV L2s. HPV51 isolated by Nuovo et al.
(1988) (Nu-strain) is indicated as HPV51-Nu and HPV51 isolated byMatsukura and Sugase (1995) (Ma-strain) is indicated as HPV51-Ma. (B) Total amino acid sequences of L2 of the
two HPV51 strains. The upper line (Nu-L2) shows amino acid sequence of L2 of HPV51 Nu-strain (deduced from the nucleotides sequences of GenBankM62877). The lower line (Ma-
L2) shows that of HPV51 Ma-strain.
260 K. Kondo et al. / Virology 394 (2009) 259–265characterized PVs by using L2s of the two strains. We found that the
reporter expression from HPV51 PVs appears to require two L2
functions: a capacity to localize in the nucleus when expressed alone
and unknown function associated with region I.
Results
Sequencing of HPV51 L1 and L2 genes
We sequenced the L1 and L2 genes of HPV51 isolated byMatsukura
and Sugase (Ma-strain) (Matsukura and Sugase, 1995) (GenBank
accession numbers for L1 and L2 genes ofMa-strain are GQ487711 and
GQ487712, respectively) and compared the deduced aa sequences
with those of the registered HPV51 (Nuovo et al., 1988) (named Nu-
strain in this study). The aa sequence of the Ma-strain L2 (Ma-L2) was
different from that of Nu-strain L2 (Nu-L2) at 6 aa positions and in
regions I and II (Fig. 1). The aa sequences of the two regions of Ma-L2
were homologous to those of the other mucosal HPVs (Fig. 1A).
The aa sequence of Ma-strain L1 (Ma-L1) was different at only four
positions (L at aa 52, G at aa 264, S at aa 265, and T at aa 272) from
those of Nu-strain L1 (Nu-L1).
Subcellular localization of the L2s
We produced codon-modiﬁed genes encoding Ma-L1, Ma-L2, and
Nu-L2, using appropriate synthetic oligonucleotides. Then, six DNA
fragments encoding chimeric L2s, from Ch1-L2 to Ch6-L2 (Fig. 2A),
were produced by PCR-based DNA synthesis.
Fig. 2B shows immunoﬂuorescence staining of the L2s transiently
expressed alone in HEK293FT cells. HEK293 cells were transfected
with the expression plasmid for L2s and ﬁxed with paraformaldehyde
1 day later. The cells were incubated with the cross-reactive anti-L2
serum, which had been produced by immunizing mice with HPV16 L2
peptide (aa 11–200), and incubated with Alexa Fluor 488-conjugated
anti-mouse IgG rabbit serum. L2 was detected by ﬂuorescencemicroscopy. Ma-L2 and Ch3-L2 were located almost exclusively in
the nucleus. Nu-L2, Ch1-L2, and Ch6-L2 were located in the
cytoplasm. Ch2-L2 was located mostly in the nucleus with ﬂuores-
cence somewhat weaker than that of Ma-L2, along with some cells
showing ﬂuorescence in both the nucleus and the cytoplasm. Ch4-L2
and Ch5-L2 were located in the nucleus, with some cells showing
cytoplasmic ﬂuorescence as well.
When Nu-L2 was co-expressed with Ma-L1, which has a strong
nuclear localizing signal (Zhou et al., 1991), the localization of Nu-L2
was shifted to the nucleus (data not presented), suggesting that Nu-L2
made a complex with Ma-L1 and moved to the nucleus with the help
of Ma-L1.
Nuclear localizing signal of HPV51 L2
Ma-L2 and Nu-L2 had two nuclear localizing signals (NSLs) at their
both ends. The DNA fragments of MA-L2 corresponding regions of aa
5–11 (encoding RARRRDR), aa 95–99 (region I, encoding VIIEPIAP-
TEPSIVNLVD), aa 179–187 (region II, encoding GHIFTSTLT), and aa
452–457 (encoding RKRRKR) were fused to the N-terminus of
enhanced green ﬂuorescent protein (EGFP). The resultant fusion
genes were transiently expressed in HEK293FT cells and localization
of EGFP was examined by ﬂuorescent microscopy (Fig. 3). The plain
EGFP was located in both of the cytoplasm and the nucleus. The EGFP
with the N-terminal region or the C-terminal region was clearly
accumulated in the nucleus. The localization of EGFPwith region I was
similar to that of plain EGFP. The EGFP with region II was located in
the nucleus slightly more than in the cytoplasm in some cells, but the
nuclear accumulation in those cells was much less than the EGFP with
the N- or C-terminal NLS. Because the aa sequences of Nu-L2 N-
terminal and C-terminal regions are identical with those of Ma-L2, the
NSLs of Nu-L2 have the same NSL sequences. Thus, the data indicate
that both terminal regions evidently contain NSLs like the L2s of
HPV6b and HPV16 (Sun et al., 1995; Darshan et al., 2004), suggesting
that Nu-L2 regions I and II inhibit the NLS function of Nu-L2.
Fig. 2. Subcellular localization of the L2s. (A) Schematic representation of the L2s used in this study. (B) Subcellular localization of the L2s. 293FT cells were transfected with the
expression plasmid for L2. One day later, the cells were ﬁxed and L2 was detected with anti-L2 mouse antiserum and Alexa Fluor 488-conjugated goat anti-mouse IgG (H+L)
(Invitrogen). The cells were coated with ProLong Gold anti-fade reagent (Invitrogen) and examined with a confocal microscope (FluoView1000, OLYMPUS, Tokyo, Japan).
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Since L2 is believed to play a critical role in the early process of
infection (Pereira et al., 2009), we prepared and characterized HPV51
PVs containing eitherMa-L2 orNu-L2. The PVswere producedby using
the codon-modiﬁed genes. HEK293FT cells were transfected with the
L1- and L2-expression plasmids together with pYSEAP, a reporter
plasmid expressing secretary alkaline phosphatase (SEAP). Sixty hours
later the nuclear extract was centrifuged on a density-gradient as
previously described (Kondo et al., 2007). A fraction containing the
majority of the PVs was used as a PV preparation. The PV preparationFig. 3. Subcellular localization of the enhanced green ﬂuorescent protein (EGFP) fused wit
plasmid for EGFP or EGFP fused with N-terminal region (aa 5–11) (EGFP-N), region I (aa 92–
(EGFP-C). One day later, the cells were ﬁxed and examined with a confocal microscope (FlproducedwithMa-L2, Nu-L2, Ch1-L2, Ch2-L2, Ch3-L2, Ch4-L2, Ch5-L2,
or Ch6-L2 was named as PV51MaL2, PV51NuL2, PV51Ch1L2,
PV51Ch2L2, PV51Ch3L2, PV51Ch4L2, PV51Ch5L2, or PV51Ch6L2,
respectively. For comparison, the nuclear extract from HEK293 cells
transfected with the L1-expression plasmid and pYSEAP, without L2-
expression plasmid, was similarly processed to produce PV51L2(−).
Transmission electron microscopy showed that PV51MaL2 and
PV51NuL2 were composed of homogeneous spherical particles with a
diameter of approximately 55 nm (Fig. 4A).
SDS–gel electrophoresis showed that all the PV preparations,
except for PV51L2(−), contained both L1 and L2 (Fig. 4B). Theh nuclear localizing signal of Ma-L2. 293FT cells were transfected with the expression
109) (EGFP-RI), region II (aa 179–187) (EGFP-RII), and C-terminal region (aa 452–457)
uoView1000, OLYMPUS, Tokyo, Japan).
Fig. 4. Characterization of HPV51 pseudovirion preparations. (A) Electron micrograph of PV51MaL2 and PV51NuL2. The pseudovirion preparation was allowed to settle on carbon-
coated copper grids and negatively stained with 4% uranylacetate. The grids were examined in a HITACHI model H-7600 transmission electron microscope and photographed at an
instrumental magniﬁcation of ×200,000. Bar=50 nm. (B) SDS–gel electrophoresis of the pseudovirion preparations. The pseudovirion preparation was mixed with an equal volume
of SDS sample buffer and boiled. Then the sample was electrophoresed on 10% SDS–polyacrylamide gel. Protein was stained with SYPRO Ruby Protein Gel Stain (Life Technologies
Corp.) and detected with a Typhoon 9410 image analyzer (GE Healthcare Life Sciences). (C) Level of the reporter plasmid packaged in the pseudovirion. The mixture of the
pseudovirion preparation and DNase-I was incubated at 37 °C for 1 hour. DNase-resistant DNA was extracted and quantiﬁed by real-time PCR with primers complementary to the
reporter plasmid, pYSEAP.
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polyacrylamide gel and stained with SYPRO Ruby Protein Gel Stain
(Life Technologies Corp.). Protein in the gel was detected with a
Typhoon 9410 image analyzer (GE Healthcare Life Sciences). The
L1-contents in the PV preparations, which were estimated by
comparison of L1-bands with BSA-bands of known amount (from
0.01 to 0.1 μg per lane) on an SDS–gel (data not shown), ranged
from 0.4 to 0.8 μg/μl. The PV preparation containing approximately
1 μg of L1 was electrophoresed and the proteins in the gel were
stained similarly. PV51MaL2 contained slightly more L2 than the
other PVs. Nu-L2, Ch2-L2, Ch3-L2, and Ch5-L2 migrated faster than
the other L2s, indicating that region I was associated with the faster
migration.
The PV preparations were found to contain the packaged reporter
plasmid at a similar level (Fig. 4C). The PV preparations containing 2
to 4 μg of L1 were digested with DNase-I extensively and the level of
the DNase-resistant pYSEAP was measured by a real-time PCRmethod. The numbers of reporter copies and the particles were
calculated from the DNA and L1 contents, respectively. The PV
preparations were estimated to contain approximately 0.3 to 1
genome copies per 100 particles; that is, the complete PVs constituted
approximately 0.3% to 1% of the particles in a preparation. It is
noteworthy that PV51L2(−) contained a similar level of the packaged
reporter, indicating that the presence of L2 did not affect the
packaging efﬁciency.
Expression of the reporter in HEK293FT cells inoculated with HPV51
pseudovirions
Fig. 5 shows the levels of reporter expression in HEK293FT cells
inoculated with the PVs. The 293FT cells (104 cells) were inoculated
with the PV preparation containing approximately 5×104 genome
copies and incubated at 37 °C for 3 days. Then, the SEAP activity of the
culture medium was measured. The cells inoculated with PV51L2(−)
Fig. 5. Expression of secretary alkaline phosphatase (SEAP) in 293FT cells inoculated
with the pseudovirion preparations. HEK293 cells inoculated with the pseudovirion
preparation were incubated for 3 days and SEAP activity of the culture medium was
measured by the colorimetric SEAP assay. Mock: SEAP activity of the culture medium of
the cells not inoculated with the pseudovirion. RLU: relative light unit.
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reporter expression. The cells inoculated with PV51MaL2, PV51Ch3L2,
and PV51Ch5L2 expressed the reporter efﬁciently and those with
PV51Ch2L2 expressed less efﬁciently. The cells inoculated with
PV51NuL2, PV51Ch1L2, PV51Ch4L2, and PV51Ch6L2 did not express
the reporter. Evidently, L2s in PV51NuL2, PV51Ch1L2, PV51Ch4L2, and
PV51Ch6L2 lacked the function required for the reporter expression.
Discussion
This study showed that the prototype HPV51 (Nuovo et al., 1988)
is likely defective because the PV containing its L2 lacks infectivity
(Fig. 5). Regions I and II of the prototype L2 were markedly different
from those of the new isolate (Matsukura and Sugase, 1995), which
were homologous to those of the other mucosal HPVs (Figs. 1A and B).
The prototype may have been cloned from defective DNA that was
integrated in the chromosome or maintained as an episome in the
cervical condyloma.
Ma-L2 expressed alone in HEK293FT cells was located exclusively
in the nucleus (Fig. 2B), perhaps by using its NLSs at the both ends as
previously shown for L2s of HPV6b and 16 (Sun et al., 1995; Darshan
et al., 2004). By contrast, Nu-L2 expressed in HEK293FT cells was
located exclusively in the cytoplasm (Fig. 2B), despite the presence of
NLS. Regions I and II of Nu-L2 probably affect the conformation of Nu-
L2 and the resultant change may inhibit the activity of NSLs. The NLS
function of chimeric L2s, having either region I or region II of Nu-L2
(Ch2-L2, Ch4-L2, and Ch5-L2), may have been partially reduced and
that of chimeric L2s, having both regions (Ch1-L2 and Ch6-L2),
markedly reduced.
Nu-L2 and three chimeric L2s, Ch1-L2, Ch4-L2, and Ch6-L2,
migrated faster than the other L2s on the SDS–gel electrophoresis
(Fig. 4B). Because only these L2s contain region I of Nu-L2, the faster
migration is probably associated with the conformational modiﬁca-
tion induced by Nu-L2 region I.
Nu-L2 was translocated to the nucleus in the cells expressing Ma-
L1, suggesting that Nu-L2 binds to L1 and makes a complex, as
described previously for HPV11 L1 and L2 (Finnen et al., 2003), and
the complex moves to the nucleus by using the NLS of L1. The L1-
mediated translocation seems to make L2s with the reduced NSL
activities possible to assemble into the particles in the nucleus.
PV51MaL2 and PV51NuL2 contained spherical particles (Fig. 4A)
composed of L1 and L2 (Fig. 4B). PV51MaL2, PV51NuL2, PV51Ch1L2,
PV51Ch2L2, PV51Ch3L2, PV51Ch4L2, PV51Ch5L2, and PV51Ch6L2
contained L1 and L2 at a comparable ratio and the DNase-resistant
(very likely packaged) reporter plasmid at similar levels (Fig. 4C).However, the reporter was expressed in HEK293FT cells inoculated
with PV51MaL2, PV51Ch2L2, PV51Ch3L2, and PV51Ch5L2 but notwith
Pv51NuL2, Pv51Ch1L2, or Pv51Ch4L2, and Pv51Ch6L2 (Fig. 5). Thus,
the PVs having Ma-L2 region I induced the expression of the reporter.
These L2s are capable of localizing in the nucleus and migrate slower
than the other L2s in the SDS–gel electrophoresis. As reported
previously for L2 of HPV16 (Day et al., 2004), probably L2 binds to
the packaged DNA and takes it to the nucleus. Then, an unknown
second function, which may be associated with L2 conformation
maintained by the aa sequence of Ma-L2 region I, helps the expression
of the reporter plasmid. Ch4-L2, which was located in the nucleus but
migrated faster, probably lacks the second function.
The reporter plasmid was packaged into PV51L2(−) similarly,
indicating that L2 is not involved in the packaging (Fig. 4C) as
reported by Buck et al. (2005). The particles containing the reporter
plasmid were approximately 0.3% to 1% of the particles in the PV
preparations. The extremely low packaging efﬁciency suggests that
the packaging occurs by chance. For the survival of HPV51 in humans,
HPV genomic DNA must have an unidentiﬁed mechanism, such as a
packaging signal, to induce efﬁcient packaging.
In summary, this study clearly showed that although HPV51 L2 is
not involved in the packaging of the reporter into the L1/L2-VLP in the
process of pseudovirion production, the expression of the packaged
reporter requires the functions of L2: its nuclear localizing capacity
and unknown function associated with aa 95–99.
Materials and methods
Cell
HEK293FT cells, a cell line expressing a high level of SV40 T-
antigen, was purchased from Life Technologies Corp. (Carlsbad, CA,
USA). The cells were cultured in Dulbecco's modiﬁed minimal
essential medium (DMEM) supplemented with 10% fetal bovine
serum, 1% non-essential amino acids (Life Technologies Corp.), 1%
GlutaMax-I (Life Technologies Corp.), and Geneticin (500 μg/ml; Life
Technologies Corp.).
Expression plasmids
The L1 and L2 genes of the cloned Ma-strain HPV51 DNA (a gift
from Dr. Toshihiko Matsukura) (Matsukura and Sugase, 1995) were
sequenced with an ABI 3130xl sequencer (Life Technologies Corp.).
The aa sequences of L1 and L2 of Matsukura strain were deduced from
the nucleotide sequences and those of Nuovo strain were deduced
from the nucleotide sequences in the database (GenBank M62877).
The nucleotide sequence of the codon-modiﬁed gene encoding the L1
or the L2was designedwith the following codons,which are usedmost
frequently in humanmRNAs; Ala: GCC; Cys: TGC; Asp: GAC; Glu; GAG;
Phe: TTC; Gly: GGC; His: CAC; Ile: ATC; Lys: AAG; Leu: CTG; Asn: AAC;
Pro: CCC; Gln: CAG; Arg; AGG; Ser: AGC; Thr: ACC; Val: GTG; Trp: TGG;
Tyr: TAC. The codon-modiﬁed geneswere produced by PCRwith sense
and antisense synthetic oligonucleotides that had an annealing region
(approximately 20 nucleotides) at its 3′ end. HPV16L1 gene inserted
between NotI and HindIII sites in p16L1h (gifts from J. T. Schiller), a
plasmid expressing the codon-modiﬁed HPV16 L1, was replaced with
the codon-modiﬁed L2 genes encoding Ma-L1, Ma-L2, and Nu-L2 to
produce pMa-L1, pMa-L2, and pNu-L2, respectively.
Three regions of the codon-modiﬁed Nu-L2 gene, nt1-96, nt1-327,
and nt1-561 (A at the ﬁrst ATG of Nu-L2 gene was numbered as nt1)
were replaced with corresponding regions of codon-modiﬁed Ma-L2
genes by using PCR to produce Ch1-L2, Ch2-L2, and Ch3-L2 genes,
respectively. The regions of the codon-modiﬁed Ma-L2 gene,
nucleotide (nt) 285 to 296 and nt 536 to 560 were replaced with
corresponding regions of codon-modiﬁed Nu-L2 gene by using PCR to
produce Ch4-L2 and Ch5-L2 genes, respectively. The region of Ch4-L2
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to nt1410, at the PmlI site to produce Ch6-L2 gene. These genes were
inserted similarly to p16L1h to produce pCh1-L2, pCh2-L2, pCh3-L2,
pCh4-L2, pCh5-L2, and pCh6-L2, respectively.
Expression plasmids for EGFP fused with L2 NSLs were produced
by insertion of the annealed synthetic oligonucleotides encoding
MVAT plus none, aa 5–11, aa 92–109, aa 179–187, and aa 452–457 of
Ma-L2 at the multicloning site of EGFP gene (pCMS-EGFP; Clontech
Inc. Mountain View, CA). The resultant fusion EGFP contained
additional aa sequences at its N-terminus.
The plasmid expressing secretary alkaline phosphatase from SV40
early promoter, pYSEAP, was a gift from J. T. Schiller.
The nucleotide sequences of the all the plasmids constructed in
this study were veriﬁed by sequencing.
Fluorescence microscopy
HEK293FT cells in an 8-well chamber plate (Nunc, Rochester, NY)
were transfected with 0.2 μg of the expression plasmid for L2 by using
Optifect transfection reagent (Invitrogen). One day later, the cells
were ﬁxed with 4% paraformaldehyde in PBS and incubated with 0.5%
Triton X-100 in PBS. The cells were reacted with anti-L2 serum
obtained by immunizingmice with HPV16L2 peptide (the region of aa
11–200), which cross-reacts with L2s of various mucosal HPVs,
followed by Alexa Fluor 488 goat anti-mouse IgG (H+L) (Invitrogen).
The cells were coated with ProLong Gold anti-fade reagent (Invitro-
gen) and examined with a confocal microscope (FluoView1000,
OLYMPUS, Tokyo, Japan).
HEK293FT cells in an 8-well chamber plate (Nunc, Rochester, NY)
were transfected with 0.2 μg of the expression plasmid for EGFP fused
with Ma-L2 NSL by using Optifect transfection reagent (Invitrogen).
One day later, the cells were ﬁxed with 4% paraformaldehyde in PBS,
coated with ProLong Gold anti-fade reagent (Invitrogen), and imaged
in a BZ-8000 ﬂuorescence microscope (Keyence, OSAKA, Japan).
Production of pseudovirions
HEK293FT cells (Life Technologies Corp.), which had been seeded
in a 10-cm culture dish (1X107 cells) at 16 hours before the
transfection, were transfected with a mixture of an L1-plasmid
(13.5 μg), an L2-plasmid (3 μg), and pYSEAP (13.5 μg) by using
Fugene HD (Rosch Diagnostics GmbH, Mannheim, Germany). Sixty
hours later, the cells were harvested with trypsin. The cells were
suspended in 0.5 ml of lysis buffer (PBS containing 1 mM CaCl2,
10 mM MgCl2, 0.35% Brij58 [Sigma-Aldrich Inc., St. Louis, MO], 0.1%
Benzonase [Sigma-Aldrich Inc.], 0.1% Plasmid Safe ATP dependent-
DNase [EPICENTRE Corp. Madison, WI]) and incubated for 30 hours at
37 °C with slow rotation. The lysate was cooled on ice for 5 minutes,
mixed with 5 M NaCl solutions to adjust the concentration of NaCl to
0.85 M, and further kept on ice for 10 minutes. Then, the lysate was
centrifuged at 5000g for 10 minutes at 4 °C. The supernatant was
layered on an Optiprep gradient (from top to bottom, 27%, 33%,
and39% in PBS containing 1 mM CaCl2, 10 mMMgCl2, and 0.8 M NaCl)
and centrifuged at 50,000 rpm for 3.5 hours at 16 °C in an SW55Ti
rotor (Beckman Coulter Inc. Fullerton, CA). Fractions (300 μl each)
were obtained by puncturing the bottom. Aliquots (5 μl per fraction)
were analyzed by SDS–gel electrophoresis. The fraction that contained
L1 most abundantly was used as a pseudovirion (PV) preparation.
Electron microscopy
The particles in a PV preparation were allowed to settle on carbon-
coated copper grids and stainedwith 4% uranylacetate. The grids were
examined in a HITACHI model H-7600 transmission electron
microscope and photographed at an instrumental magniﬁcation of
×200,000.Quantiﬁcation of L1 protein
A PV preparation (0.1 μl) or standard protein solution consisting of
the known amount (∼0.1–1 μg/μl) of bovine serum albumin (BSA)
was mixed with an equal volume of SDS sample buffer and boiled.
These samples were electrophoresed on 10% SDS–polyacrylamide gel.
Protein was stained with SYPRO Ruby Protein Gel Stain (Life
Technologies Corp.) and detected with a Typhoon 9410 image
analyzer (GE Healthcare Life Sciences). The amount of L1 protein in
the PV preparation was estimated from comparing the images
obtained with a Typhoon 9410 imaging analyzer and Image Quant
TL software (GE Healthcare, Chalfont St. Giles, UK).
Quantiﬁcation of DNase-resistant reporter DNA
Five microliters of a PV preparation was mixed with 195 μl of PBS
containing MgCl2 (10 mM) and DNase-I (70 U). After incubating at
37 °C for 1 hour, DNA was extracted by using QIAamp DNA Blood kit
(Qiagen GmbH, Hilden, Germany). pYSEAP DNA in the sample was
quantiﬁed by real-time PCR using forward primer (AGAACCCG-
GACTTCTGGAAC) and reverse primer (GGCAGCTGTCACCGTAGACA).
Quantiﬁcation of SEAP activity
A PV preparation was inoculated to HEK293FT cells (2×104),
which had been seeded 1 day prior to the inoculation in 96-well ﬂat-
bottom tissue culture-treated plates (Corning Costar Corp., New York,
NY). The cells were incubated for 3 days and SEAP activity of the
culture medium was measured by the colorimetric SEAP assay (NCI
home page: http://home.ccr.cancer.gov/lco/colorimetricseap.htm).Acknowledgments
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